EGFR/HER-targeted therapeutics in ovarian cancer.
Wilken JA, Badri T, Cross S, Raji R, Santin AD, Schwartz P, Branscum AJ, Baron AT, Sakhitab AI, Maihle NJ.
Wilken JA, et al. Among authors: maihle nj.
Future Med Chem. 2012 Mar;4(4):447-69. doi: 10.4155/fmc.12.11.
Future Med Chem. 2012.
PMID: 22416774
Free PMC article.
Review.